02/18/2026
Did you know Oscillation and Lung Expansion (OLE) therapy has been shown to significantly reduce postoperative pulmonary complications (PPCs)?
A multicenter study found OLE therapy reduced:
🔹 PPC rates by 31%
🔹 Length of stay by 1.6 days
🔹 Ventilator time by 64%
🔹 PPCs in intubated patients by 47%
These results highlight the impact OLE therapy can have on postoperative recovery.
BiWaze® Clear delivers OLE therapy through a patented dual-blower system that creates expiratory flow bias to enhance secretion clearance. It also integrates the Aerogen® Solo nebulizer for high-efficiency aerosol delivery—all in one compact system.
📖 Read the studies:
OLE: https://hubs.ly/Q043HtgZ0
Aerosol: https://hubs.ly/Q043Ht8g0
High-frequency oscillation flow and pressure study: https://hubs.ly/Q043HzKK0
Interested in learning more? Schedule a demo: https://hubs.ly/Q043Hyvg0